MX9709329A - Nuevas composiciones laxativas y su procedimiento de fabricacion. - Google Patents

Nuevas composiciones laxativas y su procedimiento de fabricacion.

Info

Publication number
MX9709329A
MX9709329A MX9709329A MX9709329A MX9709329A MX 9709329 A MX9709329 A MX 9709329A MX 9709329 A MX9709329 A MX 9709329A MX 9709329 A MX9709329 A MX 9709329A MX 9709329 A MX9709329 A MX 9709329A
Authority
MX
Mexico
Prior art keywords
compositions
monosodium
acid
rectal delivery
pharmaceutical
Prior art date
Application number
MX9709329A
Other languages
English (en)
Inventor
Axelle Note-Simonnard
Alain Sirito
Original Assignee
Techni Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techni Pharma filed Critical Techni Pharma
Publication of MX9709329A publication Critical patent/MX9709329A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Control Of Heat Treatment Processes (AREA)
  • Control Of Electric Motors In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se relaciona con el campo de la química terapéutica y más particularmente con aquel de la farmacotécnia. Por lo tanto, la invencion consiste de composiciones farmacéuticas destinadas a la vía rectal, formadas por una mezcla efervescente constituida por un bicarbonato de mateal alcalino y un compuesto de reaccion determinado que se selecciona en el grupo constituido por el fosfato monosodico o monopotásico, el citrato monosodico y el ácido glutámico, en asociacion o mezclado con uno o varios diluyentes o vehículos adaptados a la realizacion de una forma farmacéutica destinada a la vía rectal. La invencion tiene también por objeto un procedimiento para realizar composiciones farmacéuticas que se destinan a la vía rectal, que consiste en que se incorpora una sal de reaccionácida seleccionada entre el fosfato monosodico, el fosfato monopotásico, el citrato monosodico, el ácido piroglutámico y el ácido glutámico y un bicarbonato de metal alcalino, a un excipiente hidrofilo y luego a un agente opacante y se introduce esta mezcla en un excipiente graso que funde cerca de la temperatura corporal. Se utiliza como medicamento laxativo.
MX9709329A 1996-04-01 1997-12-01 Nuevas composiciones laxativas y su procedimiento de fabricacion. MX9709329A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604041A FR2746643B1 (fr) 1996-04-01 1996-04-01 Nouvelles compositions laxatives et leur procede de fabrication

Publications (1)

Publication Number Publication Date
MX9709329A true MX9709329A (es) 1998-08-30

Family

ID=9490763

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709329A MX9709329A (es) 1996-04-01 1997-12-01 Nuevas composiciones laxativas y su procedimiento de fabricacion.

Country Status (16)

Country Link
US (1) US6461638B1 (es)
EP (1) EP0833610B1 (es)
KR (1) KR100563811B1 (es)
CN (1) CN1129423C (es)
AT (1) ATE269693T1 (es)
BR (1) BR9702160A (es)
CA (1) CA2223265C (es)
DE (1) DE69729618T2 (es)
DK (1) DK0833610T3 (es)
ES (1) ES2224240T3 (es)
FR (1) FR2746643B1 (es)
HK (1) HK1016080A1 (es)
MX (1) MX9709329A (es)
NO (1) NO321425B1 (es)
PL (1) PL189874B1 (es)
WO (1) WO1997036575A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5391M (es) * 1965-11-04 1967-10-23
GB1212704A (en) * 1967-11-21 1970-11-18 Prodotti Antibiotici Spa Vaginal suppositories
FR2105111B1 (es) * 1970-09-28 1974-03-22 Sogeras
US3764668A (en) * 1970-09-30 1973-10-09 Interx Research Corp Compositions of salts of salicylamide
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
JPH0639374B2 (ja) * 1984-04-23 1994-05-25 花王株式会社 発泡性グリセリン坐剤
DE3521994A1 (de) * 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2653013B1 (fr) * 1989-10-13 1992-01-10 Oreal Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en óoeuvre dudit procede et traitement cosmetique correspondant.
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
DE69208088T2 (de) * 1991-07-05 1996-11-14 Merck Sharp & Dohme Aromatische verbindungen, diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische anwendung

Also Published As

Publication number Publication date
US6461638B1 (en) 2002-10-08
PL323624A1 (en) 1998-04-14
KR100563811B1 (ko) 2006-09-22
NO975526D0 (no) 1997-12-01
EP0833610A1 (fr) 1998-04-08
FR2746643B1 (fr) 1998-06-12
NO975526L (no) 1998-01-29
ES2224240T3 (es) 2005-03-01
WO1997036575A1 (fr) 1997-10-09
DE69729618T2 (de) 2005-07-14
PL189874B1 (pl) 2005-10-31
EP0833610B1 (fr) 2004-06-23
CA2223265A1 (fr) 1997-10-09
DE69729618D1 (de) 2004-07-29
HK1016080A1 (en) 1999-10-29
KR19990022279A (ko) 1999-03-25
DK0833610T3 (da) 2004-10-25
NO321425B1 (no) 2006-05-08
BR9702160A (pt) 1999-03-02
CA2223265C (fr) 2005-02-08
CN1194579A (zh) 1998-09-30
FR2746643A1 (fr) 1997-10-03
CN1129423C (zh) 2003-12-03
ATE269693T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
IL100328A0 (en) Dihydro isoquinoline derivatives,their production and pharmaceutical compositions containing them
DK0909166T3 (da) Fremgangsmåde til fremstilling af medicinsk tyggegummi med en behagelig smag indeholdende et inklusionskompleks
ATE200226T1 (de) Zusammensetzungen die verwendbar sind zur verabreichung von therapeutisch wirksamer polynukleotiden in eine zielzelle und ihre verwendung in gentherapie
IL114127A0 (en) Thrombin inhibiting compounds
PH23248A (en) Process for the preparation of quinolone-carboxylic acid
CA2311922A1 (en) Thienopyrimidines
MY129437A (en) Drug formulation having controlled release of active compound
PT885014E (pt) Composicoes farmaceuticas contendo polimeros orto ester tamponados
DE60231747D1 (de) Verfahren zur herstellung und verwendung von theaflavin, theaflavin-3-gallat, theaflavin-3'-gallat und theaflavin 3,3'-digallat und ihrer gemische
HU9300115D0 (en) Arabino-furanosyl-purine derivatives and method for producing them
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
ES8608313A1 (es) Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable.
DE3685052D1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
MX9709329A (es) Nuevas composiciones laxativas y su procedimiento de fabricacion.
IL70445A (en) Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
SE9803478L (sv) Förfarande för framställning av näringstillskott för djur
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
HUT58089A (en) Process for producing 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic aci derivatives and pharmaceutical compositions comprising such compounds as active ingredient
SI0805817T1 (es)
YU15182A (en) Process for preparing base-substituted anthrnilic acid
PH24526A (en) Novel imidazo and triazolothiadiazines and medicaments containing same
DE3263688D1 (en) Pyridazinone imines and their physiologically tolerable addition salts, process for their preparation and therapeutical agents containing those compounds
JPS5261286A (en) Preparation of enzymes